Biotechnology Department, Medical Genetics Section, University of Siena, Siena, Italy.
J Hum Genet. 2011 Jul;56(7):508-15. doi: 10.1038/jhg.2011.50. Epub 2011 May 19.
MECP2 mutations are responsible for two different phenotypes in females, classical Rett syndrome and the milder Zappella variant (Z-RTT). We investigated whether copy number variants (CNVs) may modulate the phenotype by comparison of array-CGH data from two discordant pairs of sisters and four additional discordant pairs of unrelated girls matched by mutation type. We also searched for potential MeCP2 targets within CNVs by chromatin immunopreceipitation microarray (ChIP-chip) analysis. We did not identify one major common gene/region, suggesting that modifiers may be complex and variable between cases. However, we detected CNVs correlating with disease severity that contain candidate modifiers. CROCC (1p36.13) is a potential MeCP2 target, in which a duplication in a Z-RTT and a deletion in a classic patient were observed. CROCC encodes a structural component of ciliary motility that is required for correct brain development. CFHR1 and CFHR3, on 1q31.3, may be involved in the regulation of complement during synapse elimination, and were found to be deleted in a Z-RTT but duplicated in two classic patients. The duplication of 10q11.22, present in two Z-RTT patients, includes GPRIN2, a regulator of neurite outgrowth and PPYR1, involved in energy homeostasis. Functional analyses are necessary to confirm candidates and to define targets for future therapies.
MECP2 突变可导致女性出现两种不同表型,即经典雷特综合征和较温和的 Zappella 变异型(Z-RTT)。我们通过比较两对存在分歧的姐妹和四对具有相同突变类型的不相关女孩的比较基因组杂交(array-CGH)数据,研究了拷贝数变异(CNVs)是否可以通过比较基因组杂交(array-CGH)数据来调节表型。我们还通过染色质免疫沉淀微阵列(ChIP-chip)分析寻找潜在的 MeCP2 靶点。我们没有发现一个主要的共同基因/区域,这表明修饰因子可能在病例之间复杂且多变。然而,我们检测到与疾病严重程度相关的包含候选修饰因子的 CNV。CROCC(1p36.13)是一个潜在的 MeCP2 靶点,在一个 Z-RTT 中观察到重复,在一个经典患者中观察到缺失。CROCC 编码纤毛运动的结构成分,对于正确的大脑发育是必需的。CFHR1 和 CFHR3,位于 1q31.3,可能参与突触消除过程中的补体调节,在一个 Z-RTT 中观察到缺失,而在两个经典患者中观察到重复。10q11.22 的重复存在于两个 Z-RTT 患者中,包括 GPRIN2,一种神经突生长的调节剂,以及 PPYR1,参与能量稳态。需要进行功能分析来确认候选基因,并为未来的治疗确定靶点。